Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Medtronic
Cantor Fitzgerald
Colorcon
Julphar
Fuji
Accenture
AstraZeneca

Generated: June 19, 2018

DrugPatentWatch Database Preview

VIOCIN SULFATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Viocin Sulfate patents expire, and when can generic versions of Viocin Sulfate launch?

Viocin Sulfate is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in VIOCIN SULFATE is viomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the viomycin sulfate profile page.
Summary for VIOCIN SULFATE
Drug patent expirations by year for VIOCIN SULFATE
Medical Subject Heading (MeSH) Categories for VIOCIN SULFATE
Synonyms for VIOCIN SULFATE
(3R)-3,6-diamino-N-[(3R,6Z,9S,12R,15R)-3-[(4S)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanamide;
(3S)-3,6-diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4S,6R)-2-amino-4-hydroxy-1,4,5,6-tetrahydropyrimidin-6-yl]-6-[(carbamoylamino)methylidene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentazacyclohexadec-15-yl]hexanami
1404-97-3
19272-75-4
34458-90-7
37883-00-4
AC1MHWUU
AC1NR05G
C25H43N13O10
CAS-37883-00-4
CCG-221113
Celicomycin-sulfate
D02270
D0Q8NJ
DSSTox_CID_26290
DSSTox_GSID_46290
DSSTox_RID_81516
DTXSID60872306
Florimycin sulfate
HMS2098O08
LKO141R05V
LS-162213
NCGC00160671-01
NOCAS_872306
SCHEMBL1235403
Solfato di viomicina
Solfato di viomicina [Italian]
SR-01000872697
SR-01000872697-1
Tox21_111975
UNII-LKO141R05V
Viocin
Viocin (TN)
Viomycin mono sulfate
VIOMYCIN SULFATE
Viomycin sulfate (JAN)
Viomycin sulfate (TN)
Viomycin sulfate [USP]
Viomycin-sulfat
Viomycin-sulfat [German]
Viomycin, sulfate (salt)
Viomycinsulfat

US Patents and Regulatory Information for VIOCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer VIOCIN SULFATE viomycin sulfate INJECTABLE;INJECTION 061086-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer VIOCIN SULFATE viomycin sulfate INJECTABLE;INJECTION 061086-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Baxter
Argus Health
Chinese Patent Office
Fuji
Federal Trade Commission
Merck
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.